Craft

RenovaCare

Stock Price

$0

2024-10-29

Market Capitalization

$8.7 K

2024-10-29

RenovaCare Summary

Company Summary

Overview
RenovaCare, Inc. is a biotechnology company focused on developing first-of-their-kind autologous (self-donated) stem cell therapies for the regeneration of human organs. The Company's initial products under development target the body’s largest organ, the skin. The Company's flagship technology, the CellMist System, uses our patented SkinGun to spray a liquid suspension of a patient’s stem cells – the CellMist Solution – onto wounds. RenovaCare, Inc. is also developing medical-grade liquid spray devices for wound care and irrigation fluids.
Type
Public
Status
Active
HQ
Roseland, NJ, US | view all locations
Website
http://renovacareinc.com/
Cybersecurity rating
Sectors

Key People

  • Harmel S. Rayat

    Harmel S. Rayat, Chairman of the Board of Directors

    • Kaiyo Nedd

      Kaiyo Nedd, President & Chief Executive Officer

      • Robin A. Robinson

        Robin A. Robinson, Chief Scientific Officer

        • Jo Ellen Schweinle

          Jo Ellen Schweinle, Chief Medical Officer

          LocationsView all

          4 locations detected

          • Roseland, NJ HQ

            United States

            3 Becker Farm Rd Suite 105

          • Pittsburgh, PA

            United States

            Carson

          • Scottsdale, AZ

            United States

            9375 E Shea Blvd 107 a

          • Berlin, Berlin

            Germany

            Germaniastraße 18-20/Aufgang C

          RenovaCare Financials

          Summary Financials

          Net income (Q3, 2022)
          ($400.4K)
          Cash (Q3, 2022)
          $100.7K
          EBIT (Q3, 2022)
          ($1.9M)

          Footer menu